View in EDS HTML Full Text PDF Full Text

The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience.

Saved in:
Bibliographic Details
Title: The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience.
Authors: Olszewska-Szopa, Magdalena1 (AUTHOR), Ożańska, Agnieszka1 (AUTHOR) aozanska@usk.wroc.pl, Ożański, Tomasz2 (AUTHOR), Rybka, Justyna1 (AUTHOR), Wróbel, Tomasz1 (AUTHOR)
Source: Leukemia & Lymphoma. Jan2024, Vol. 65 Issue 1, p55-61. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 174756677
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Olszewska-Szopa%2C+Magdalena%22">Olszewska-Szopa, Magdalena</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ożańska%2C+Agnieszka%22">Ożańska, Agnieszka</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> aozanska@usk.wroc.pl</i><br /><searchLink fieldCode="AR" term="%22Ożański%2C+Tomasz%22">Ożański, Tomasz</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rybka%2C+Justyna%22">Rybka, Justyna</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wróbel%2C+Tomasz%22">Wróbel, Tomasz</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Jan2024, Vol. 65 Issue 1, p55-61. 7p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=174756677
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2023.2271595
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 55
    Titles:
      – TitleFull: The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Olszewska-Szopa, Magdalena
      – PersonEntity:
          Name:
            NameFull: Ożańska, Agnieszka
      – PersonEntity:
          Name:
            NameFull: Ożański, Tomasz
      – PersonEntity:
          Name:
            NameFull: Rybka, Justyna
      – PersonEntity:
          Name:
            NameFull: Wróbel, Tomasz
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 10428194
          Numbering:
            – Type: volume
              Value: 65
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Leukemia & Lymphoma
              Type: main
ResultId 1